Fig. 3From: Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencingROC curves for MAPD, ndSNPQC and SM score, showing their effect on putative positive calls. For MAPD, there was a simple pass/fail threshold. For ndSNPQC, some samples were considered borderline quality. For SM score, “failed” calls were all called as negative for a mutation. We imposed a borderline cut-off of ten based on results of previous analysesBack to article page